Resona Asset Management Co. Ltd. Takes $17.37 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Resona Asset Management Co. Ltd. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 57,801 shares of the company’s stock, valued at approximately $17,370,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Whipplewood Advisors LLC acquired a new position in HCA Healthcare in the 4th quarter valued at approximately $31,000. Tidemark LLC bought a new position in HCA Healthcare during the 4th quarter worth $36,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Activest Wealth Management raised its position in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. boosted its holdings in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of analyst reports. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Truist Financial lowered their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Royal Bank of Canada reduced their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. Finally, Morgan Stanley cut their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $332.53 on Friday. The stock’s fifty day simple moving average is $327.23 and its two-hundred day simple moving average is $339.47. The stock has a market cap of $81.87 billion, a PE ratio of 15.14, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company posted $5.90 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were given a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.87%. HCA Healthcare’s payout ratio is currently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.